Bayesian adaptive design for pediatric clinical trials incorporating a community of prior beliefs

被引：0
作者：
Yu Wang
James Travis
Byron Gajewski
机构：
[1] University of Kansas Medical Center,Department of Biostatistics & Data Science
[2] U.S. Food and Drug Administration,Division of Biometrics II, Office of Biostatistics, Office of Translational Sciences, Center of Drug Evaluation and Research
来源：
BMC Medical Research Methodology | / 22卷
关键词：
Bayesian adaptive design; Pediatric clinical trials; Prior belief; Interim analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 66 条
[1]  
Gamalo-Siebers M(2017)Statistical modeling for Bayesian extrapolation of adult clinical trial information in pediatric drug evaluation Pharm Stat 16 232-249
[2]  
Allen HC(2018)Off-Label Medication use in Children, More Common than We Think: A Systematic Review of the Literature J Okla State Med Assoc 111 776-783
[3]  
Neel DV(2019)Timing of first-in-child trials of FDA-approved oncology drugs Eur J Cancer 112 49-56
[4]  
Shulman DS(2015)Clinical trials in children Br J Clin Pharmacol 79 357-369
[5]  
Dubois SG(2004)Clinical trials in children The Lancet 364 803-811
[6]  
Joseph PD(2015)Placebo-controlled trials in pediatrics and the child’s best interest Ital J Pediatr 41 11-6
[7]  
Craig JC(2012)Use of Bayesian statistics in drug development: Advantages and challenges Int J Appl Basic Med Res 2 3-1027
[8]  
Caldwell PHY(2008)Adaptive design methods in clinical trials – a review Orphanet J Rare Dis 3 11-821
[9]  
Caldwell PH(2020)Comparison of Bayesian and frequentist group-sequential clinical trial designs BMC Med Res Methodol. 20 4-1334
[10]  
Di Pietro ML(2018)A Bayesian Phase I/II Trial Design for Immunotherapy J Am Stat Assoc 113 1016-205
1234567